A citation-based method for searching scientific literature

Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A Kushner, Pablo Lapuerta, Darren K McGuire, Anne L Peters, Sangeeta Sawhney, Paul Strumph. Diabetes Care 2018
Times Cited: 89







List of co-cited articles
593 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Kidney Effects of Empagliflozin in People with Type 1 Diabetes.
David Z I Cherney, Petter Bjornstad, Bruce A Perkins, Julio Rosenstock, Dietmar Neubacher, Jan Marquard, Nima Soleymanlou. Clin J Am Soc Nephrol 2021
1
100

Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine.
Dorte Vistisen, Gregers Stig Andersen, Christian Stevns Hansen, Adam Hulman, Jan Erik Henriksen, Henning Bech-Nielsen, Marit Eika Jørgensen. Circulation 2016
82
1

Predicting major outcomes in type 1 diabetes: a model development and validation study.
Sabita S Soedamah-Muthu, Yvonne Vergouwe, Tina Costacou, Rachel G Miller, Janice Zgibor, Nish Chaturvedi, Janet K Snell-Bergeon, David M Maahs, Marian Rewers, Carol Forsblom,[...]. Diabetologia 2014
31
3

Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines.
Andrea Marshall, Douglas G Altman, Roger L Holder, Patrick Royston. BMC Med Res Methodol 2009
399
1

Presence and Determinants of Cardiovascular Disease and Mortality in Individuals With Type 1 Diabetes of Long Duration: The FinnDiane 50 Years of Diabetes Study.
Valma Harjutsalo, Drazenka Pongrac Barlovic, Daniel Gordin, Carol Forsblom, George King, Per-Henrik Groop. Diabetes Care 2021
3
33



The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
Erik J M van Bommel, Marcel H A Muskiet, Michaël J B van Baar, Lennart Tonneijck, Mark M Smits, Anna L Emanuel, Andrea Bozovic, A H Jan Danser, Frank Geurts, Ewout J Hoorn,[...]. Kidney Int 2020
131
1

Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
Marco Colombo, Stuart J McGurnaghan, Samira Bell, Finlay MacKenzie, Alan W Patrick, John R Petrie, John A McKnight, Sandra MacRury, Jamie Traynor, Wendy Metcalfe,[...]. Diabetologia 2020
11
9

A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes.
Dorte Vistisen, Gregers S Andersen, Adam Hulman, Stuart J McGurnaghan, Helen M Colhoun, Jan E Henriksen, Reimar W Thomsen, Frederik Persson, Peter Rossing, Marit E Jørgensen. Diabetes Care 2021
7
14

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
B M Brenner, M E Cooper, D de Zeeuw, W F Keane, W E Mitch, H H Parving, G Remuzzi, S M Snapinn, Z Zhang, S Shahinfar. N Engl J Med 2001
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.